Skip to main content
ConductScienceScienceDex

John V. Heymach

NIH Rank #8322
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1894553Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,322
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John V. Heymach. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing John V. Heymach as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA287279-01A1R01
    Deciphering the structural determinants of response and resistance to HER2-targeted antibody-drug conjugates and tyrosine kinase inhibitors for HER2-mutant Non-Small Cell Lung Cancer
    UT MD Anderson Cancer Center
    $695K
    award amount
  • 5U01CA256780-05U01
    Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
    UT MD Anderson Cancer Center
    $605.5K
    award amount
  • 5P30CA016672-49P30
    Cancer Center Support Grant
    UT MD Anderson Cancer Center
    $426.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing John V. Heymach as a PI.

FY2025 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4741
  6. 2024
    Entered Top 25% Nationally
    Ranked #4741
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as John V. Heymach.

Anil K Sood
UT MD Anderson Cancer Center
2
shared awards
Christopher J. Logothetis
UT MD Anderson Cancer Center
2
shared awards
David S. Hong
UT MD Anderson Cancer Center
2
shared awards
Diane Bodurka
UT MD Anderson Cancer Center
2
shared awards
Dihua Yu
UT MD Anderson Cancer Center
2
shared awards
Eduardo Vilar Sanchez
UT MD Anderson Cancer Center
2
shared awards
Elizabeth J Shpall
UT MD Anderson Cancer Center
2
shared awards
Ernest T. Hawk
UT MD Anderson Cancer Center
2
shared awards
Fernando J Benavides
UT MD Anderson Cancer Center
2
shared awards
Funda Meric-bernstam
UT MD Anderson Cancer Center
2
shared awards

Explore further

Find collaborators for John V. Heymach

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →